Valuation: DocMorris AG

Market Cap 54Cr 65Cr 57Cr 49Cr 92Cr 6.28TCr 92Cr 645.91Cr 249.25Cr 3.19TCr 246.01Cr 240.55Cr 10TCr P/E 2026 *
-6.62x
P/E 2027 * -15.2x
Enterprise Value 74Cr 90Cr 79Cr 67Cr 126.16Cr 8.64TCr 126.69Cr 888.26Cr 342.78Cr 4.39TCr 338.32Cr 330.81Cr 14TCr EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.55x
Free-Float
62.21%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
7.45
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
422.96
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 65Cr
+0.17%+4.43%-46.20%-9.49% 1.47TCr
-1.02%+2.24%-16.86%-6.90% 633.67Cr
-4.40%-2.33%-55.34%-34.89% 631.5Cr
+0.13%+1.33%-9.67%-22.89% 412.1Cr
+0.11%+0.06%-19.57%-37.74% 313.36Cr
+0.38%+3.84%+6.00%-29.71% 312.34Cr
-1.05%+9.67%-43.95%-22.01% 292.79Cr
-0.13%+3.09%+76.92% - 284.98Cr
-1.19%-2.68%-21.86%-10.64% 238.38Cr
Average -3.42%+2.08%-14.50%-21.78% 510.44Cr
Weighted average by Cap. -1.15%+2.65%-25.72%-18.55%

Financials

2026 *2027 *
Net sales 126.14Cr 153.2Cr 133.59Cr 114.54Cr 214.61Cr 15TCr 215.5Cr 1.51TCr 583.07Cr 7.47TCr 575.49Cr 562.71Cr 24TCr 140.51Cr 170.65Cr 148.81Cr 127.59Cr 239.06Cr 16TCr 240.05Cr 1.68TCr 649.5Cr 8.33TCr 641.05Cr 626.82Cr 27TCr
Net income -8.59Cr -10Cr -9.1Cr -7.8Cr -15Cr -1TCr -15Cr -102.9Cr -40Cr -508.98Cr -39Cr -38Cr -1.64TCr -3.89Cr -4.73Cr -4.12Cr -3.54Cr -6.62Cr -453.78Cr -6.65Cr -47Cr -18Cr -230.71Cr -18Cr -17Cr -742.33Cr
Net Debt 20Cr 25Cr 21Cr 18Cr 34Cr 2.36TCr 35Cr 242.35Cr 94Cr 1.2TCr 92Cr 90Cr 3.86TCr 23Cr 28Cr 25Cr 21Cr 39Cr 2.71TCr 40Cr 278.05Cr 107.3Cr 1.38TCr 105.9Cr 103.55Cr 4.43TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
10.68CHF
Average target price
11.29CHF
Spread / Average Target
+5.75%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!